Search

everythinglearnresearchcommunity

for

Search:↓

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Hormones affect skin aging, and treatments targeting hormonal balance may improve skin health.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Finasteride and minoxidil are effective for hair regrowth, while treatments for alopecia areata have varying success and continuous treatment is necessary.

Only minoxidil and finasteride are FDA-approved for hair loss, with other treatments available but less effective or with side effects.

The document concludes that understanding hair follicle biology can lead to better hair loss treatments.

Estrogens significantly influence hair growth by interacting with receptors in hair follicles and may help regulate the hair growth cycle.

The document concludes that blocking the internal pathways that create androgens might help treat cancers that depend on sex hormones.

The document concludes that understanding hair and feather regeneration can help develop new regenerative medicine strategies.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Insulin resistance and high male hormone levels are major causes of Polycystic Ovary Syndrome.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

The review recommends hormone replacement therapy for women with premature ovarian insufficiency to manage symptoms and protect health, with specific approaches for different groups.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

PCOS often causes skin issues like excess hair, acne, and hair loss, needing early treatment.

Effective PCOS treatments require targeting specific signaling pathways.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Men and women experience skin aging differently due to changes in sex hormone levels with age.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

The mineralocorticoid receptor may play a role in skin and hair health and could be a new target for treating related disorders.

Researchers created a mouse model of a type of rickets that does not cause hair loss.

The foreword introduces a medical issue discussing male hormonal health, treatments, and the effects of conditions like obesity and aging.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Androgen suppression therapy (AST) doesn't significantly lower bladder cancer risk, but using finasteride, a type of AST, might reduce it. AST decreases recurrence-free survival but doesn't affect overall survival or progression-free survival. More research is needed to understand AST's benefits.